St. Joseph’s Medical Center is bringing advanced cancer care to San Joaquin County with a new collaboration between St. Joseph’s Regional Cancer Center and the UCSF Helen Diller Family Comprehensive Cancer Center that will enhance patient care and access to clinical trials.
December 04, 2012
The Regional Cancer Center at ValleyCare and UCSF Helen Diller Family Comprehensive Cancer Center have joined forces to enhance patient care and improve access to top level medical experts.
November 08, 2012
A 20-year study following 110,645 workers who helped clean up after the 1986 Chernobyl nuclear power plant accident shows that the workers share a significant increased risk of developing leukemia.
November 01, 2012
A new molecular test developed by doctors at UCSF may give doctors the ability to better predict post-operative early-stage lung cancer mortality.
September 18, 2012
A once-promising discovery linking prostate cancer to an obscure retrovirus derived from mice was the result of an inadvertent laboratory contamination, a forensic analysis of tissue samples and lab experiments – some dating back nearly a decade – has confirmed.
August 07, 2012
Marin County, Calif., has one of the highest rates of breast cancer in the world, a fact that scientists know has nothing to do with the land itself but with some other, unknown factor.
July 24, 2012
A UCSF team has harnessed a natural protein in bacteria to create a “pause switch” in immune cells, potentially leading to more effective and safer immune therapies for diseases such as cancer and multiple sclerosis.
July 16, 2012
UCSF researchers triggered cellular transformation — and caused tumors to form in mice — by activating just two genes, a discovery that suggests drugs that are able to target those genes may provide a way to treat the deadly cancer, known as cholangiocarcinoma.
July 10, 2012
Cancer patients across the country have a new way to navigate through difficult treatment decisions and communicate better with their doctors. “Open to Options,’’ which recently launched nationally, was developed in conjunction with UCSF to guide patients in making critical health decisions.
July 01, 2012
People with lung cancer who are treated with the drug Tarceva face a daunting uncertainty: although their tumors may initially shrink, it's not a question of whether their cancer will return—it's a question of when. And for far too many, it happens far too soon.